Immediate Impact
59 standout
Citing Papers
Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease
2023 Standout
Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products
2022 Standout
Works of N M Lunde being referenced
Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease
2007
A Comparison of Dosing Regimens of Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in CKD Stages 3 and 4
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| N M Lunde | 114 | 96 | 18 | 88 | 12 | 297 | |
| Nathalie Terrier | 175 | 37 | 52 | 29 | 15 | 334 | |
| John R. Foringer | 77 | 116 | 13 | 90 | 11 | 301 | |
| Joseph A. Coladonato | 236 | 101 | 6 | 94 | 10 | 333 | |
| Rosemarie A. Baillod | 91 | 68 | 30 | 55 | 15 | 272 | |
| Robert F. Slifkin | 121 | 59 | 25 | 50 | 15 | 299 | |
| Gensy M.W. Tong | 171 | 78 | 3 | 69 | 22 | 303 | |
| Edouard Blanc | 97 | 44 | 57 | 20 | 16 | 320 | |
| D. Hauglustaine | 104 | 68 | 6 | 12 | 19 | 312 | |
| Peter Hollett | 174 | 28 | 37 | 32 | 11 | 316 | |
| Sunny S.H. Wong | 198 | 80 | 6 | 39 | 12 | 315 |
All Works
Loading papers...